Patent approved in Europe | IDL Biotech
IDL Biotech

CLOSE MENU

Articles

Lung cancer

March 2018

Patent approved in Europe

During 2015 the patent ”Method for detection of cytokeratin 8, 18 and/or 19 and/or soluble fragments thereof” was approved in Sweden. In September 2017 the patent was approved in China. The patent has now also been approved in Europe and is valid until 2034.

Information from the Annual General Meeting

The Annual General meeting was held on the 28th of May 2019.

Christmas Holiday

We would like to inform you that our office will be closed, due to Christmas and New Years Holidays during the following period December 24th 2018 to January 6th, 2019. Full operations will resume on January the 7th.

IDL Biotech

Skip this intro